Detalhe da pesquisa
1.
Introducing neurofilament light chain measure in psychiatry: current evidence, opportunities, and pitfalls.
Mol Psychiatry;
2024 Mar 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38503931
2.
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study.
Ann Neurol;
91(1): 33-47, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34743360
3.
Serum NfL but not GFAP predicts cognitive decline in active progressive multiple sclerosis patients.
Mult Scler;
29(2): 206-211, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36448331
4.
Accuracy of serum neurofilament light to identify contrast-enhancing lesions in multiple sclerosis.
Mult Scler;
29(11-12): 1418-1427, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37712409
5.
Younger age at multiple sclerosis onset is associated with worse outcomes at age 50.
J Neurol Neurosurg Psychiatry;
2022 Aug 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35953266
6.
Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing-remitting MS.
Mult Scler;
28(4): 573-582, 2022 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34378446
7.
Classification of multiple sclerosis based on patterns of CNS regional atrophy covariance.
Hum Brain Mapp;
42(8): 2399-2415, 2021 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33624390
8.
Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis.
Mult Scler;
27(1): 52-60, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31961243
9.
Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis.
Mult Scler;
27(13): 2014-2022, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33635141
10.
Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis.
Mult Scler;
27(2): 220-231, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32255388
11.
Central nervous system atrophy predicts future dynamics of disability progression in a real-world multiple sclerosis cohort.
Eur J Neurol;
28(12): 4153-4166, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34487400
12.
Neurological symptoms and blood neurofilament light levels.
Acta Neurol Scand;
144(1): 13-20, 2021 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33734429
13.
Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity.
Mult Scler;
26(2): 210-219, 2020 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30570436
14.
Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study.
Mult Scler;
26(13): 1670-1681, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31610732
15.
Neurofilament light levels are associated with long-term outcomes in multiple sclerosis.
Mult Scler;
26(13): 1691-1699, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31680621
16.
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis.
Mult Scler;
25(5): 678-686, 2019 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29542376
17.
Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches.
Clin Chem Lab Med;
57(10): 1556-1564, 2019 Sep 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31251725
18.
Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy.
J Peripher Nerv Syst;
24(2): 187-194, 2019 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30973667
19.
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.
Brain;
141(8): 2382-2391, 2018 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29860296
20.
Serum neurofilament light chain as a prognostic marker in postanoxic encephalopathy.
Epilepsy Behav;
101(Pt B): 106432, 2019 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31375414